AGGRESSIVE B-CELL LYMPHOMA WITH SECONDARY INVOLVEMENT OF THE CNS

Clinical trials for AGGRESSIVE B-CELL LYMPHOMA WITH SECONDARY INVOLVEMENT OF THE CNS explained in plain language.

Never miss a new study

Get alerted when new AGGRESSIVE B-CELL LYMPHOMA WITH SECONDARY INVOLVEMENT OF THE CNS trials appear

Sign up with your email to follow new studies for AGGRESSIVE B-CELL LYMPHOMA WITH SECONDARY INVOLVEMENT OF THE CNS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug cocktail tested for Tough-to-Treat brain cancers

Disease control Ongoing

This early-phase study is testing the safety of a combination of five drugs (called VIPOR) for people with aggressive B-cell lymphomas that involve the brain or spinal cord. The trial is for adults whose cancer has come back, stopped responding to treatment, or who cannot receive…

Matched conditions: AGGRESSIVE B-CELL LYMPHOMA WITH SECONDARY INVOLVEMENT OF THE CNS

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 18, 2026 14:42 UTC

AGGRESSIVE B-CELL LYMPHOMA WITH SECONDARY INVOLVEMENT OF THE CNS

Get alerted when new AGGRESSIVE B-CELL LYMPHOMA WITH SECONDARY INVOLVEMENT OF THE CNS trials appear

New drug cocktail tested for Tough-to-Treat brain cancers